Study of a new drug for active ankylosing spondylitis
Part of Bones, joints & muscles clinical trials.
This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have been diagnosed with ankylosing spondylitis using the 1984 modified New York criteria.
- You have tried NSAIDs (like ibuprofen) and they didn't work well enough, or you can't take them.
- You are willing to use birth control and not plan pregnancy or donate sperm/eggs for at least 6 months after the last dose.
- You do not have other uncontrolled inflammatory diseases, active hepatitis B, C, or HIV, a history of cancer, or a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication called LNK01001 for adults with active ankylosing spondylitis. It aims to reduce pain, stiffness, and inflammation when standard NSAID treatments no longer help.
This trial tests whether combining two biologic medications (adalimumab and secukinumab) can better relieve symptoms of ankylosing spondylitis, a type of arthritis that affects the spine. It may help if you have not responded well to standard nonsteroidal anti-inflammatory drugs (NSAIDs) and you have active disease.
This trial tests whether a single infusion of stem cells from a healthy donor's bone marrow can help reduce inflammation and pain in people with active ankylosing spondylitis. If you are young and have not been helped by standard treatments, this study might offer a new option.
This study looks at treatments for people with ankylosing spondylitis, a type of arthritis that affects the spine. It aims to find better ways to manage symptoms and improve quality of life.
This study tests a new treatment using umbilical cord stem cells given by injection to help reduce inflammation and improve symptoms of ankylosing spondylitis. It is for people who have not gotten enough relief from standard medications, including biologics.
This study compares two types of biologic drugs (IL-17 inhibitors vs. anti-TNF drugs) in people with ankylosing spondylitis (a form of arthritis affecting the spine) who have already tried standard treatments. The goal is to see which drug works better for controlling symptoms.
Hear when a new Ankylosing Spondylitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.